Clinical trial
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 Over 21 Days in Ambulatory Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease
NCT06482437 is registered in ClinicalTrials.gov with NMD Pharma A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 Over 21 Days in Ambulatory Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease
- Lead sponsor
- NMD Pharma A/S
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2024
- Completion date
- November 4, 2025
- Enrollment
- 81 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.